DMCA Copyright Policy

Effective Date: 02/12/2025
Last Updated: 02/12/2025

BioTech Times (“we”, “our”, “us”, “the Website”) respects the intellectual property rights of others. It is our policy to respond to clear notices of alleged copyright infringement that comply with the Digital Millennium Copyright Act (DMCA) and other applicable laws.

This DMCA Policy outlines how copyright owners may request the removal of infringing content and how users may respond to such notices.

1. Copyright Infringement Notification

If you believe that any content on BioTech Times (biotechtimes.in) infringes upon your copyright, please send us a written notice containing the following information (required by law):

  1. A physical or electronic signature of the copyright owner or an authorized representative.
  2. Identification of the copyrighted work claimed to have been infringed.
  3. Identification of the material that is claimed to be infringing—including URLs or direct links—to help us locate it.
  4. Your contact information, including:
    • Full name
    • Email address
    • Phone number
  5. A statement that you have a good-faith belief that the disputed use is not authorized by the copyright owner, its agent, or the law.
  6. A statement, under penalty of perjury, that the information in the notice is accurate and that you are the copyright owner or authorized to act on their behalf.

Please send your DMCA Notice to:

📧 Email: support@biotechtimes.in

2. Removal of Allegedly Infringing Content

Upon receiving a valid DMCA Notice:

  • We will review the complaint.
  • We may remove or disable access to the allegedly infringing material.
  • We will notify the content uploader or author (if applicable).
  • We may terminate accounts or block users who repeatedly violate copyright rights.

We reserve the right to remove content without notice if it appears to infringe on copyright laws.

3. Counter-Notification (If You Believe Your Content Was Removed in Error)

If you believe your content was wrongly removed or disabled due to a misidentification or mistake, you may submit a Counter-Notice that includes:

  1. Your physical or electronic signature.
  2. Identification of the removed content and its location prior to removal.
  3. A statement under penalty of perjury that the content was removed as a result of mistake or misidentification.
  4. Your name, address, email, and phone number.
  5. A statement consenting to the jurisdiction of the courts in Uttarakhand, India (or your local region if different).
  6. A statement agreeing to accept service of legal documents from the person who submitted the original DMCA Notice.

Counter-Notices should be sent to:

📧 Email: support@biotechtimes.in

If a valid Counter-Notice is received, we may restore the removed content unless the copyright owner files a legal action within 14 days.

4. Repeat Infringer Policy

BioTech Times reserves the right to:

  • Suspend, restrict, or terminate user access
  • Remove postings
  • Block IP addresses
  • Take any required legal or administrative action

against any user found repeatedly infringing copyright or posting unauthorized content.

5. Misrepresentation Warning

Under the DMCA, knowingly submitting false claims (either a DMCA Notice or Counter-Notice) can result in:

  • Legal penalties
  • Damages
  • Court fees
  • Liability under applicable copyright laws

Please file DMCA submissions accurately and responsibly.

6. Changes to This Policy

BioTech Times may modify this DMCA Policy at any time. Updated versions will be posted on this page. Continued use of the Website implies acceptance of any changes.

7. Contact Information

For all copyright-related inquiries:

📧 Email: support@biotechtimes.in
🌐 Website: https://biotechtimes.in